Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by ScienceGirlon Dec 19, 2017 3:27pm
174 Views
Post# 27189828

CBD: WHO Report Finds No Public Health Risks

CBD: WHO Report Finds No Public Health Risks Hey guys, looking at the stock price may be killing us right now so I figured we can focus on the positives. I know Tetra is an all-plant extract proponent, but cannabis strains naturally have differing amounts of CBD, THC, to the point some have almost no THC. This article is positive in the sense that if there is no THC in the extract, there will be less barriers to getting the extract in the patient's hands. Anyways, something to keep in mind. Article can be found here: https://www.forbes.com/sites/janetwburns/2017/12/11/who-report-finds-no-public-health-risks-abuse-potential-for-cbd/#7f2a9dee6b88 This may be particularly beneficial in their collaboration with Constance Therapeutics, as it looks like different cancer forms respond differently to THC and CBD. Not sure which type of plant extract they will be using for trials with Tetra, but I guess we will find out soon! A whole bunch of research is posted on Constance T. website: https://www.constancetherapeutics.com/research-index/#/learn-more-section
<< Previous
Bullboard Posts
Next >>
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse